Pharmaxon secures $2.54 million investment from Primaveris and SHAM - MarketLine Financial Deals

Pharmaxon secures $2.54 million investment from Primaveris and SHAM

Pharmaxon secures $2.54 million investment from Primaveris and SHAM - MarketLine Financial Deals
Pharmaxon secures $2.54 million investment from Primaveris and SHAM
Published Nov 25, 2009
2 pages — Published Nov 25, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Pharmaxon, a biopharmaceutical company, has secured EUR1.7 million investment.

  
Source:
Document ID
MA20017_100224
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Pharmaxon secures $2.54 million investment from Primaveris and SHAM" Nov 25, 2009. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pharmaxon-secures-2-54-million-investment-from-Primaveris-and-SHAM-2052-26103>
  
APA:
MarketLine Financial Deals. (2009). Pharmaxon secures $2.54 million investment from Primaveris and SHAM Nov 25, 2009. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pharmaxon-secures-2-54-million-investment-from-Primaveris-and-SHAM-2052-26103>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.